CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES: WHAT DOES GOLD CLAIM?
Rubrics: VIROLOGY
Abstract and keywords
Abstract (English):
The article highlights the issue of a modern approach to the management of patients with chronic obstructive pulmonary disease occurring in comorbidity with cardiovascular diseases, according to modern recommendations - Global initiative for chronic Obstructive Lung Disease 2023, as well as on the basis of data reflected in the medical literature at the present time.

Keywords:
chronic obstructive pulmonary disease, comorbidity, cardiovascular diseases, clinical recommendations
Text
Publication text (PDF): Read Download
References

1. Vizel', I. Yu. Rezul'taty dinamicheskogo nablyudeniya za bol'nymi hronicheskoy obstruktivnoy bolezn'yu legkih (hobl) v techenie 2-5 let. Obzor literatury / I. Yu. Vizel', E. I. Shmelev, A. A. Vizel' // Vestnik sovremennoy klinicheskoy mediciny. - 2009. - T. 2, № 1. - S. 27-31. - EDN NEAYSF.

2. Vishnyak, D. A. Dinamika parametrov funkcii vneshnego dyhaniya i razvitie koronarnyh katastrof u pacientov s hronicheskoy obstruktivnoy bolezn'yu legkih na Severe / D. A. Vishnyak, M. A. Popova // Arhiv' vnutrenney mediciny. - 2019. - T. 9, № 2(46). - S. 117-125. - DOIhttps://doi.org/10.20514/2226-6704-2019-9-2-117-125. - EDN ZATOJV.

3. Diagnostika i lechenie pacientov s arterial'noy gipertoniey i hronicheskoy obstruktivnoy bolezn'yu legkih(Rekomendacii Rossiyskogo medicinskogo obschestva po arterial'noy gipertonii i Rossiyskogo respiratornogo obschestva) / I. E. Chazova, A. G. Chuchalin, K. A. Zykov, L. G. Ratova // Sistemnye gipertenzii. - 2013. - T. 10, № 1. - S. 5-34. - EDN QZUWPV.

4. Dolgopolova, D. A. Novye podhody k ocenke hronicheskoy obstruktivnoy bolezni legkih na Severe: opredelenie gruppy riska / D. A. Dolgopolova, I. I. Zayceva // Vrach-aspirant. - 2014. - T. 65, № 4. - S. 11-16. - EDN SZEPRZ.

5. Dolgopolova, D. A. Koronarnyy risk pri hronicheskoy obstruktivnoy bolezni legkih: novye otvety na starye voprosy / D. A. Dolgopolova // Vrach-aspirant. - 2015. - T. 73, № 6.2. - S. 234-239. - EDN VKUKOT.

6. Dolgopolova, D. A. Ocenka vozmozhnosti primeneniya shkaly SCORE v prognozirovanii serdechno-sosudistyh sobytiy u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih / D. A. Dolgopolova, M. A. Popova, I. V. Veden'kina // Sovremennye problemy nauki i obrazovaniya. - 2014. - № 2. - S. 388. - EDN SBWIAZ.

7. Klinicheskaya patofiziologiya narusheniy mozgovogo krovoobrascheniya: novye metody diagnostiki, profilaktiki i lecheniya / V. P. Kulikov, M. L. Dicheskul, S. V. Zasorin [i dr.] // Problemy klinicheskoy mediciny. - 2014. - № 3-4(34). - S. 40-56. - EDN UYXEJJ.

8. Komorbidnost' pri HOBL: rol' hronicheskogo sistemnogo vospaleniya / A. L. Vertkin, A. S. Skotnikov, E. Yu. Tihonovskaya [i dr.] // RMZh. Medicinskoe obozrenie. - 2014. - T. 22, № 11. - S. 811-816. - EDN SKBNMF.

9. Kucenko, M. A. Paradigma komorbidnosti: sintropiya HOBL i IBS / M. A. Kucenko, A. G. Chuchalin // RMZh. - 2014. - T. 22, № 5. - S. 389-392. - EDN SLROLX.

10. Makarova, M. A. Arterial'naya rigidnost' i endotelial'naya disfunkciya u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih / M. A. Makarova, S. N. Avdeev // Pul'monologiya. - 2011. - № 4. - S. 109-117. - EDN OHXOXD.

11. Osobennosti remodelirovaniya serdca u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih, sochetannoy s ishemicheskoy bolezn'yu serdca / T. G. Shapovalova, N. V. Shelobanova, M. V. Volkova [i dr.] // Saratovskiy nauchno-medicinskiy zhurnal. - 2009. - T. 5, № 3. - S. 352-355. - EDN KXPINP.

12. Ostroumova, O. D. Hronicheskaya obstruktivnaya bolezn' legkih i komorbidnye serdechno-sosudistye zabolevaniya: vzglyad s poziciy rekomendaciy / O. D. Ostroumova, A. I. Kochetkov // Consilium Medicum. - 2018. - T. 20, № 1. - S. 54-61. - DOIhttps://doi.org/10.26442/2075-1753_2018.1.54-61. - EDN RQSAAD.

13. Popova, M. A. Morfofunkcional'nye izmeneniya serdca pri razlichnom serdechno-sosudistom riske u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih / M. A. Popova, D. A. Dolgopolova, I. V. Veden'kina // V mire nauchnyh otkrytiy. - 2012. - № 5-3(29). - S. 55-69. - EDN PBVNAT.

14. Strukturno funkcional'noe sostoyanie serdca i perifericheskih sosudov pri arterial'noy gipertonii v sochetanii s hronicheskoy obstruktivnoy bolezn'yu legkih v dinamike lecheniya / I. S. Shpagin, A. V. Shabalin, L. A. Shpagina [i dr.] // Pul'monologiya. - 2010. - № 5. - S. 61-68. - EDN MXQQYD.

15. Chuchalin, A. G. Hronicheskaya obstruktivnaya bolezn' legkih i soputstvuyuschie zabole-vaniyaChast' I. HOBL i porazheniya serdechno-sosudistoy sistemy / A. G. Chuchalin // RMZh. - 2008. - T. 16, № 2. - S. 58-64. - EDN THXAZP.

16. Abusaid GH, Barbagelata A, Tuero E, Mahmood A, Sharma G. Diastolic dysfunction and COPD exacerbation. Postgrad Med 2009; 121(4): 76-81.

17. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162(4): 237-51

18. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21(6): 1012-6

19. Dransfield MT, Criner GJ, Halpin DMG, et al. Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial. J Am Heart Assoc 2022; 11(18): e024350

20. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31(1): 204-12.

21. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease. GOLD 2023.https://goldcopd.org/2023-gold-report-2/

22. Hole, D. J. Impaired lung function and mortality risk in men and women: findings from the Ren-frew and Paisley prospective population study / D. J. Hole, G. C. Watt, G. Davey-Smith [et al.] // Br. Med. J. - 1996. - 313. -711-715.

23. Krahnke JS, Abraham WT, Adamson PB, et al. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail 2015; 21(3): 240-9.

24. Liu X, Chen Z, Li S, Xu S. Association of Chronic Obstructive Pulmonary Disease With Arrhyth-mia Risks: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021; 8: 732349.

25. Lopez-Sanchez M, Munoz-Esquerre M, Huertas D, et al. High Prevalence of Left Ventricle Dias-tolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study. PLoS One 2013; 8(6): e68034.

26. Makris, D. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers / D. Makris, J. Moschandreas, A. Damianaki [et al.] // Respir. Med. - 2007. -Vol. 101, № 6. - P.1305-1312.

27. Matamis D, Tsagourias M, Papathanasiou A, et al. Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life. J Crit Care 2014; 29(2): 315 e7-14.

28. MacDonald MI, Shafuddin E, King PT, Chang CL, Bardin PG, Hancox RJ. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med 2016; 4(2): 138-48.

29. Persson, C. Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothen-burg, Sweden / C. Persson, C. Bengtsson, L. Lapidus [et al.] // Am J Epidemiol. - 1986. - Vol. 124. - R. 942-948.

30. Sin, D. D. Inhaled corticosteroids and mortality in chronic obstructive pulmo-nary disease / D. D. Sin, L. Wu, J. A. Anderson [et al.] // Thorax. - 2005. - Vol.60. - P.992-997.

31. Yeoh SE, Dewan P, Serenelli M, et al. Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EM-PHASIS-HF and RALES. Eur J Heart Fail 2022; 24(3): 529-38

Login or Create
* Forgot password?